JULIE HARRINGTON: Open Payments
NPI 1083955462 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 28 payments from 10 companies in 2025. Trend: 2023 $900 · 2024 $897 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $192 |
| Regeneron Healthcare Solutions, Inc. | 5 | $94 |
| Lilly USA, LLC | 5 | $84 |
| ABBVIE INC. | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Incyte Corporation | 1 | $21 |
| PFIZER INC. | 1 | $17 |
| UCB, Inc. | 1 | $17 |
Products named: DUPIXENT, TALTZ, SKYRIZI, COSENTYX, TREMFYA, NEMLUVIO, OPZELURA, LIBTAYO.
Industry payments across FL — which companies pay providers there.
